September 27, 2022MedStar Health Awarded Additional $2 Million Grant to Expand Research on National Telehealth Access, Safety, and Health Equity
New research will build on findings of study recently published by npj Digital Medicine and policy insights on telehealth access resulting from the first round of funding COLUMBIA, Md. — MedStar...
October 01, 2019
Washington, D.C. – MedStar Heart & Vascular Institute has enrolled its first patient to a clinical trial to determine whether cardiac stem cells reduce inflammation enough to improve heart functio...
June 13, 2019
WASHINGTON — A combination of elevated symptoms of depression along with modifications in a gene responsible for dopamine activity, important to the brain’s pleasure and reward system, appear to influ...
May 07, 2019National Cancer Institute Renews Prestigious Designation of Georgetown Lombardi Comprehensive Cancer CenterMedStar Washington Hospital Center Patients Will Benefit from Increased Access to the Nation’s Leading Experts and Research
March 13, 2019
WASHINGTON — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases level...
February 08, 2019Large Study Reveals Long-Term Outcomes for Prostate Cancer Patients Treated with High Dose, Short Term Radiation Like CyberKnife Radiotherapy
WASHINGTON –– A large, national study examining a radiation treatment for prostate cancer––popular because it delivers a high dose of therapy in a very short time fra...
January 30, 2019
Hyattsville, MD (January 31, 2019) — Three research projects at MedStar Health Research Institute were awarded grant funding through the Charles and Mary Latham Fund. The Fund ...